← All organizations

Adrenomed AG

For profitWebsite ↗

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

May 1, 2017

Timeline

2000s

Jun 1, 2009
Adrenomed AG— Founded

Drugs by trial phase (2 distinct, 3 trials)

Phase 2 (1 own, 0 via acquisition)

adrecizumab

Phase 1 (1 own, 0 via acquisition)

endotoxin

Indications

Studied for

Recent trials (4)

NCT03085758Lead sponsorPhase 2May 1, 2017
NCT03085758Study directorPhase 2May 1, 2017
NCT03083171Lead sponsorPhase 1Jan 4, 2017
NCT02991508CollaboratorPhase 1May 23, 2016

Details

Founded: Berlin, DE Jun 1, 2009
Last known activity: May 1, 2017